Curioler — home
Behaviour
Tier 3 · Clinical consensus

Why this tier: Randomized Controlled Trial (small sample)

Sungeun Kang, Karen Burkett, Shivali Sarawgi, Jenna Ruberg, Jamisen Paustian, Debra L Reisinger, Lauren M Schmitt, Rebecca C Shaffer (2026) Regulating Together: Caregivers' experiences in a shared journey through an emotion dysregulation intervention for autistic youth. Research in developmental disabilities doi:10.1016/j.ridd.2026.105317
Randomized Controlled Trial

Regulating Together: Caregivers' experiences in a shared journey through an emotion dysregulation intervention for autistic youth.

Research in developmental disabilities · 2026 · PMID 42217453 · 2 min read

Easy explainer

This was a randomised controlled trial — people were assigned to treatments by chance, which is the most reliable way to tell whether a treatment itself caused a change.

It involved only 12 people. Random assignment still means the groups started out comparable, but with so few people the result can shift a lot by chance — a larger trial could easily find something different. Treat this as an early signal rather than an answer.

The abstract does not include a conclusions section, so this page does not state what the researchers concluded.

This record does not state:

  • the ages of the people who took part
  • how long the study ran

This is a plain-language summary of one paper's abstract, not medical advice. Talk to your child's clinician before changing anything.

Study details

Journal: Research in developmental disabilities

Year: 2026

Design: Randomized Controlled Trial

Participants: 12

Intervention: Emotion dysregulation

Authors: Sungeun Kang, Karen Burkett, Shivali Sarawgi, Jenna Ruberg, Jamisen Paustian, Debra L Reisinger, Lauren M Schmitt, Rebecca C Shaffer

Abstract

Autistic children are more likely to experience challenges with emotion regulation, which affect their academic, social, and other developmental outcomes. Emerging manualized programs have begun to address this gap, including Regulating Together (RT), a group-based outpatient intervention that incorporates concurrent caregiver training. This qualitative study explored caregivers' perceptions and experiences with the RT intervention. Semi-structured interviews were conducted with twelve caregivers of autistic children following program completion within a randomized controlled trial. Thematic analysis identified six overarching themes: (1) recognizing early signs and building child regulation skills, (2) caregivers' experiences of program value, structure, and application, (3) caregivers' growth as self-regulated learners and supportive coaches, (4) the power of communal learning and growth, (5) creating inclusive spaces through diverse voices, and (6) ecological barriers that impeded practice and participation. Caregivers described benefits of participating in RT and reported positive outcomes for both themselves and their children. Overall, the RT model shows nuanced dyadic child and caregiver learning and growth in addressing emotion dysregulation in autistic children and offers a potentially inclusive model for supporting families. Findings also signify how ecological challenges shaped participation and implementation, highlighting the need for future manualized interventions to account for contextual factors in program design and delivery. TRIAL REGISTRATION: Trial registration took place through ClinicalTrials.gov (NCT05803369).

Source

Research in developmental disabilities, 2026

PMID 42217453

DOI 10.1016/j.ridd.2026.105317

This record was extracted from the paper's PubMed abstract and metadata. Full-text methods and risk-of-bias details were not reviewed.

Source: Sungeun Kang, Karen Burkett, Shivali Sarawgi, Jenna Ruberg, Jamisen Paustian, Debra L Reisinger, Lauren M Schmitt, Rebecca C Shaffer (2026) Regulating Together: Caregivers' experiences in a shared journey through an emotion dysregulation intervention for autistic youth. Research in developmental disabilities doi:10.1016/j.ridd.2026.105317

This is informational content, not medical advice — see our disclaimer.